Dose Ranging Study in Healthy Methadone Maintenance Subjects

Bausch Health Americas, Inc.16 enrolled

Overview

To assess the effect of a single oral dose of MOA-728, an investigational drug, on the oral-cecal transit time in subjects who are taking methadone.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

DOUBLE

Enrollment

Conditions

Adult

Interventions

MOA-728DRUG

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 YearsHealthy volunteers:

Medical Language ↔ Plain English

1. Men or nonlactating and nonpregnant women, aged 18 to 65 years 2. Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead electrocardiogram

Locations (1)

Unnamed facility

Lenexa, Kansas, United States

Outcomes

Primary Outcomes

Oral-cecal transit time will be evaluated.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.